Newsroom

COPENHAGEN, Denmark & WILMINGTON, Del.--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) and Incyte (Nasdaq: INCY) today announced a clinical trial collaboration to evaluate petosemtamab, Genmab’s investigational IgG1-bispecific antibody targeting the epidermal growth factor receptor (EGFR) and leucine-rich repeat containing G-protein-coupled receptor 5 (LGR5), in combination with INCB161734, Incyte’s investigational, potent and selective KRAS G12D inhibitor, and standard-of-care chemotherapy as a fi...

WILMINGTON, Del. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer...

ニューヨーク--(BUSINESS WIRE)--（ビジネスワイヤ） -- ライフゾーン・メタルズ・リミテッド（NYSE：LZM）は、オリオン・リソース・パートナーズの創業者兼グループ最高経営責任者であるOskar Lewnowski氏が、タンザニアにおけるライフゾーン・メタルズの「カバンガ・ニッケル・プロジェクト」に関してブルームバーグテレビジョンのインタビューで述べた内容についてお知らせします。 インタビュー後にメディアや投資家から寄せられた問い合わせを受け、ライフゾーン・メタルズは、カバンガ・ニッケル・プロジェクトへの大規模な出資を巡るオリオン重要鉱物コンソーシアム（Orion CMC）との交渉がかなり進展していることを確認しました。 Orion CMCは、オリオン・リソース・パートナーズが米国国際開発金融公社（DFC）およびアブダビの政府系投資会社ADQと提携して立ち上げたグローバル投資プラットフォームです。 既に発表しているとおり、ライフゾーン・メタルズは、カバンガ・ニッケル・プロジェクトへの戦略的投資を確保するため、スタンダードチャータード銀行が主導する競争的プロセスを進...

MUNICH & SAN FRANCISCO--(BUSINESS WIRE)--CatalYm today announced final results from its randomized Phase 2 GDFATHER-NEO trial, which were presented in a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 and simultaneously published in Nature Medicine. The data showed that Growth Differentiation Factor-15 (GDF-15) blockade with visugromab substantially enhanced the anti-tumor activity of the PD‑1 inhibitor nivolumab in the neoadjuvant treatment of patients with...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph....

TORONTO--(BUSINESS WIRE)--Slate Grocery REIT (TSX: SGR.U) (TSX: SGR.UN) (the “REIT”), an owner and operator of U.S. grocery-anchored real estate, announced today that it has obtained an interim order (the “Interim Order”) of the Ontario Superior Court of Justice (Commercial List) (the “Court”) in connection with the proposed acquisition by EP/BRX Holdings LLC (the “Purchaser”), a joint venture between an affiliate of Brixmor Property Group Inc. and affiliates of Everview Partners, L.P., of all...

HANOVRE, Allemagne--(BUSINESS WIRE)--Bodor Laser présentera deux nouvelles machines haut de gamme de découpe laser de tubes à l’EuroBLECH 2026, qui feront leurs débuts européens lors du plus grand salon mondial dédié à l’usinage de la tôle. L’événement se tiendra du 20 au 23 octobre à Hanovre. Bodor Laser sera présent dans le hall 13, aux stands A181 et A182, sur une surface d’exposition de plus de 1 400 m². Ces deux nouvelles machines offrent des solutions distinctes pour améliorer la producti...

HANNOVER, Germania--(BUSINESS WIRE)--Bodor Laser presenterà per la prima volta in Europa due nuove macchine laser premium per il taglio di tubi a EuroBLECH 2026, la fiera commerciale leader al mondo per la lavorazione della lamiera. L'evento si terrà dal 20 al 23 ottobre ad Hannover, e Bodor Laser sarà presente nella Hall 13, stand A181 e A182, su una superficie espositiva di oltre 1.400 m². Le due nuove macchine offrono percorsi distinti in direzione di una produttività superiore per la lavora...

KENNETT SQUARE, Pa.--(BUSINESS WIRE)--Genesis Healthcare, Inc. (“Genesis”) today announced that its chapter 11 plan became effective, following the closing of the sale of substantially all of its operating assets to 101 W. State Street, LLC (“West State Street”) on October 14, 2026.On behalf of the Board of Directors, the Company thanks its management team, its employees and staff for their focus and dedication throughout the chapter 11 process. Despite a long and complex case, the Company’s fin...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of NVE Corporation (NASDAQ: NVEC) resulting from allegations that NVE Corporation may have issued materially misleading business information to the investing public. So What: If you purchased NVE Corporation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee...